Titre :
  • Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
Auteur : Gerrard, M. ; Cairo, MS ; Weston, C. ; Auperin, A. ; Pinkerton, C Ross ; Lambilliote, A. ; Sposto, R. ; McCarthy, K. ; Lacombe, MJ ; Perkins, S.L. ; Patte, Catherine ; Sariban, Eric
Informations sur la publication : British journal of haematology, 141, 6, (page 840-847)
Statut de publication : Publié, 2008-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adolescent
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Asparaginase -- adverse effects
Asparaginase -- therapeutic use
Child
Child, Preschool
Combined Modality Therapy
Cyclophosphamide -- adverse effects
Cyclophosphamide -- therapeutic use
Cytarabine -- adverse effects
Cytarabine -- therapeutic use
Doxorubicin -- adverse effects
Doxorubicin -- therapeutic use
Female
Follow-Up Studies
Humans
Infant
Lymphoma, B-Cell -- drug therapy
Lymphoma, B-Cell -- pathology
Lymphoma, B-Cell -- surgery
Male
Methotrexate -- adverse effects
Methotrexate -- therapeutic use
Neoplasm Staging
Prednisone -- adverse effects
Prednisone -- therapeutic use
Survival Analysis
Treatment Failure
Treatment Outcome
Vincristine -- adverse effects
Vincristine -- therapeutic use
Note : Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
FLWIN
Langue :
  • Anglais
Identificateurs : urn:issn:0007-1048 
info:doi/10.1111/j.1365-2141.2008.07144.x
info:pii/BJH7144
info:pmid/18371107